ALKEMNSEAlkem Laboratories LimitedMediumNeutral
Announced Tue, 31 Mar · 18:46 IST

Alkem Laboratories Limited has informed the Exchange change in Senior Management

Management Changes View source PDF

ALKEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.5%1-day move
₹5300.00
prior close
₹5320.50
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.0+2.3+2.2+1.6-0.5-1.0-2.4-1.2+1.6+0.9-1.1+1.5+0.3+4.9
Up moveDown movePending
AI summary

Alkem Laboratories has informed the exchanges about two changes in its senior management. Mr. Ravinder Chaklam has superannuated (retired) from the company and ceases to hold a senior management position effective 24th March 2026. Separately, Mr. Mukesh Tiwari has been appointed in a wholly owned subsidiary of the company and accordingly ceases to hold a senior management position in the listed entity effective 1st October 2025. The company filed the disclosure on 31st March 2026 and noted that the delay was unintentional due to an inadvertent oversight. No brief profiles or relationship disclosures were provided for either individual.

Likely market impact

These are routine senior management transitions rather than material events. Shareholders are unlikely to see a significant impact on the stock, as one change is a planned retirement and the other is an internal move to a subsidiary role.